Atezolizumab + intravesical BCG (bacillus Calmette-Guerin) upfront combination in high risk non-muscle- invasive bladder cancer (NMIBC) patients: Safety interim report of BladderGATE phase I-II study.
Atezolizumab;Bacillus Calmette-Guerin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Atezolizumab + intravesical BCG (bacillus Calmette-Guerin) upfront combination in high risk non-muscle- invasive bladder cancer (NMIBC) patients: Safety interim report of BladderGATE phase I-II study. ### Output: Atezolizumab;Bacillus Calmette-Guerin